Click to Share

Filter News
Show All Results
News By Country
News By Tag
Drug Formulation Remove

July 2017

Public Company News

Business Press Releases

Drug Formulation Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

By SMi Group
SMi reports: (2015.11.05, Iselin, New Jersey, USA): Leading organizations in the Biosimilars Development sector will meet at Biosimilars and Biobetters USA 2015 – the must-attend premier industry event which will take place in Iselin this November
By Cambridge Healthtech Institute
The Accelerating Development of Difficult-to-Deliver Drugs conference will discuss the role of novel delivery strategies and advanced tools in developing difficult-to-deliver drugs.
By Masha Skvirtchak
We are less than two months away from a must attend educational and networking event for scientific and business leaders involved in drug delivery and formulation to discuss the current challenges and new strategies to succeed in this evolving area.
By Integral BioSystems, LLC
Boston area CRO Integral BioSystems, LLC announces its participation in the 2010 International Pharmaceutical Federation's PSWC/AAPS Annual Meeting Exposition in New Orleans November 14 - 18
By SEOP, Inc.
UPM Pharmaceuticals, an independent drug development company, offers third-party services for drug formulation. The company's expert formulators help optimize the form and formula to create effective drug medications.
By SEOP Inc.
UPM Pharmaceuticals provides drug development services including formulation development, GMP manufacturing, and stability testing. The company embodies scientific superiority and display flexibility, receptiveness, and originality.
By World Trade Group
Dates: 26th – 27th January 2010 Location: Radisson BLU Scandinavia Hotel, Dusseldorf, Germany. Major biotech and pharma players will gather, in Dusseldorf, to discuss drug delivery and formulation
By Xcelience
Continues Growth Despite Challenging Economy
By Derek Hennecke
Xcelience, a leader in early drug development services, has developed a faster, more cost effective path to Phase I studies using Xcelodose® 600/600 S precision powder micro-dosing systems (Xcelodose® is a registered trademark of Capsugel® BVBA).

Page updated every 10 minutes

Like PRLog?
Click to Share